Global Gene Therapy for Sickle Cell Disease Market Research Report 2026

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy for Sickle Cell Disease Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Gene Addition Therapies
1.2.3 Gene Editing Therapies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gene Therapy for Sickle Cell Disease Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Children and Adolescents
1.3.3 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy for Sickle Cell Disease Market Perspective (2021–2032)
2.2 Global Gene Therapy for Sickle Cell Disease Growth Trends by Region
2.2.1 Global Gene Therapy for Sickle Cell Disease Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Gene Therapy for Sickle Cell Disease Historic Market Size by Region (2021–2026)
2.2.3 Gene Therapy for Sickle Cell Disease Forecasted Market Size by Region (2027–2032)
2.3 Gene Therapy for Sickle Cell Disease Market Dynamics
2.3.1 Gene Therapy for Sickle Cell Disease Industry Trends
2.3.2 Gene Therapy for Sickle Cell Disease Market Drivers
2.3.3 Gene Therapy for Sickle Cell Disease Market Challenges
2.3.4 Gene Therapy for Sickle Cell Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy for Sickle Cell Disease Players by Revenue
3.1.1 Global Top Gene Therapy for Sickle Cell Disease Players by Revenue (2021–2026)
3.1.2 Global Gene Therapy for Sickle Cell Disease Revenue Market Share by Players (2021–2026)
3.2 Global Top Gene Therapy for Sickle Cell Disease Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Gene Therapy for Sickle Cell Disease Revenue
3.4 Global Gene Therapy for Sickle Cell Disease Market Concentration Ratio
3.4.1 Global Gene Therapy for Sickle Cell Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Sickle Cell Disease Revenue in 2025
3.5 Global Key Players of Gene Therapy for Sickle Cell Disease Head Offices and Areas Served
3.6 Global Key Players of Gene Therapy for Sickle Cell Disease, Products and Applications
3.7 Global Key Players of Gene Therapy for Sickle Cell Disease, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Gene Therapy for Sickle Cell Disease Breakdown Data by Type
4.1 Global Gene Therapy for Sickle Cell Disease Historic Market Size by Type (2021–2026)
4.2 Global Gene Therapy for Sickle Cell Disease Forecasted Market Size by Type (2027–2032)
5 Gene Therapy for Sickle Cell Disease Breakdown Data by Application
5.1 Global Gene Therapy for Sickle Cell Disease Historic Market Size by Application (2021–2026)
5.2 Global Gene Therapy for Sickle Cell Disease Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Gene Therapy for Sickle Cell Disease Market Size (2021–2032)
6.2 North America Gene Therapy for Sickle Cell Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Gene Therapy for Sickle Cell Disease Market Size by Country (2021–2026)
6.4 North America Gene Therapy for Sickle Cell Disease Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy for Sickle Cell Disease Market Size (2021–2032)
7.2 Europe Gene Therapy for Sickle Cell Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Gene Therapy for Sickle Cell Disease Market Size by Country (2021–2026)
7.4 Europe Gene Therapy for Sickle Cell Disease Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy for Sickle Cell Disease Market Size (2021–2032)
8.2 Asia-Pacific Gene Therapy for Sickle Cell Disease Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Gene Therapy for Sickle Cell Disease Market Size by Region (2021–2026)
8.4 Asia-Pacific Gene Therapy for Sickle Cell Disease Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Gene Therapy for Sickle Cell Disease Market Size (2021–2032)
9.2 Latin America Gene Therapy for Sickle Cell Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Gene Therapy for Sickle Cell Disease Market Size by Country (2021–2026)
9.4 Latin America Gene Therapy for Sickle Cell Disease Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy for Sickle Cell Disease Market Size (2021–2032)
10.2 Middle East & Africa Gene Therapy for Sickle Cell Disease Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Gene Therapy for Sickle Cell Disease Market Size by Country (2021–2026)
10.4 Middle East & Africa Gene Therapy for Sickle Cell Disease Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vertex Pharmaceuticals
11.1.1 Vertex Pharmaceuticals Company Details
11.1.2 Vertex Pharmaceuticals Business Overview
11.1.3 Vertex Pharmaceuticals Gene Therapy for Sickle Cell Disease Introduction
11.1.4 Vertex Pharmaceuticals Revenue in Gene Therapy for Sickle Cell Disease Business (2021–2026)
11.1.5 Vertex Pharmaceuticals Recent Development
11.2 Bluebird bio
11.2.1 Bluebird bio Company Details
11.2.2 Bluebird bio Business Overview
11.2.3 Bluebird bio Gene Therapy for Sickle Cell Disease Introduction
11.2.4 Bluebird bio Revenue in Gene Therapy for Sickle Cell Disease Business (2021–2026)
11.2.5 Bluebird bio Recent Development
11.3 Editas Medicine
11.3.1 Editas Medicine Company Details
11.3.2 Editas Medicine Business Overview
11.3.3 Editas Medicine Gene Therapy for Sickle Cell Disease Introduction
11.3.4 Editas Medicine Revenue in Gene Therapy for Sickle Cell Disease Business (2021–2026)
11.3.5 Editas Medicine Recent Development
11.4 CRISPR Therapeutics
11.4.1 CRISPR Therapeutics Company Details
11.4.2 CRISPR Therapeutics Business Overview
11.4.3 CRISPR Therapeutics Gene Therapy for Sickle Cell Disease Introduction
11.4.4 CRISPR Therapeutics Revenue in Gene Therapy for Sickle Cell Disease Business (2021–2026)
11.4.5 CRISPR Therapeutics Recent Development
11.5 Beam Therapeutics
11.5.1 Beam Therapeutics Company Details
11.5.2 Beam Therapeutics Business Overview
11.5.3 Beam Therapeutics Gene Therapy for Sickle Cell Disease Introduction
11.5.4 Beam Therapeutics Revenue in Gene Therapy for Sickle Cell Disease Business (2021–2026)
11.5.5 Beam Therapeutics Recent Development
11.6 Intellia Therapeutics
11.6.1 Intellia Therapeutics Company Details
11.6.2 Intellia Therapeutics Business Overview
11.6.3 Intellia Therapeutics Gene Therapy for Sickle Cell Disease Introduction
11.6.4 Intellia Therapeutics Revenue in Gene Therapy for Sickle Cell Disease Business (2021–2026)
11.6.5 Intellia Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Gene Therapy for Sickle Cell Disease Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Gene Addition Therapies
Table 3. Key Players of Gene Editing Therapies
Table 4. Key Players of Others
Table 5. Global Gene Therapy for Sickle Cell Disease Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Gene Therapy for Sickle Cell Disease Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Gene Therapy for Sickle Cell Disease Market Size by Region (US$ Million), 2021–2026
Table 8. Global Gene Therapy for Sickle Cell Disease Market Share by Region (2021–2026)
Table 9. Global Gene Therapy for Sickle Cell Disease Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Gene Therapy for Sickle Cell Disease Market Share by Region (2027–2032)
Table 11. Gene Therapy for Sickle Cell Disease Market Trends
Table 12. Gene Therapy for Sickle Cell Disease Market Drivers
Table 13. Gene Therapy for Sickle Cell Disease Market Challenges
Table 14. Gene Therapy for Sickle Cell Disease Market Restraints
Table 15. Global Gene Therapy for Sickle Cell Disease Revenue by Players (US$ Million), 2021–2026
Table 16. Global Gene Therapy for Sickle Cell Disease Market Share by Players (2021–2026)
Table 17. Global Top Gene Therapy for Sickle Cell Disease Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gene Therapy for Sickle Cell Disease Revenue, 2025
Table 18. Ranking of Global Top Gene Therapy for Sickle Cell Disease Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Gene Therapy for Sickle Cell Disease Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Gene Therapy for Sickle Cell Disease, Headquarters and Area Served
Table 21. Global Key Players of Gene Therapy for Sickle Cell Disease, Products and Applications
Table 22. Global Key Players of Gene Therapy for Sickle Cell Disease, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Gene Therapy for Sickle Cell Disease Market Size by Type (US$ Million), 2021–2026
Table 25. Global Gene Therapy for Sickle Cell Disease Revenue Market Share by Type (2021–2026)
Table 26. Global Gene Therapy for Sickle Cell Disease Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Gene Therapy for Sickle Cell Disease Revenue Market Share by Type (2027–2032)
Table 28. Global Gene Therapy for Sickle Cell Disease Market Size by Application (US$ Million), 2021–2026
Table 29. Global Gene Therapy for Sickle Cell Disease Revenue Market Share by Application (2021–2026)
Table 30. Global Gene Therapy for Sickle Cell Disease Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Gene Therapy for Sickle Cell Disease Revenue Market Share by Application (2027–2032)
Table 32. North America Gene Therapy for Sickle Cell Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Gene Therapy for Sickle Cell Disease Market Size by Country (US$ Million), 2021–2026
Table 34. North America Gene Therapy for Sickle Cell Disease Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Gene Therapy for Sickle Cell Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Gene Therapy for Sickle Cell Disease Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Gene Therapy for Sickle Cell Disease Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Gene Therapy for Sickle Cell Disease Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Gene Therapy for Sickle Cell Disease Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Gene Therapy for Sickle Cell Disease Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Gene Therapy for Sickle Cell Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Gene Therapy for Sickle Cell Disease Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Gene Therapy for Sickle Cell Disease Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Gene Therapy for Sickle Cell Disease Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Gene Therapy for Sickle Cell Disease Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Gene Therapy for Sickle Cell Disease Market Size by Country (US$ Million), 2027–2032
Table 47. Vertex Pharmaceuticals Company Details
Table 48. Vertex Pharmaceuticals Business Overview
Table 49. Vertex Pharmaceuticals Gene Therapy for Sickle Cell Disease Product
Table 50. Vertex Pharmaceuticals Revenue in Gene Therapy for Sickle Cell Disease Business (US$ Million), 2021–2026
Table 51. Vertex Pharmaceuticals Recent Development
Table 52. Bluebird bio Company Details
Table 53. Bluebird bio Business Overview
Table 54. Bluebird bio Gene Therapy for Sickle Cell Disease Product
Table 55. Bluebird bio Revenue in Gene Therapy for Sickle Cell Disease Business (US$ Million), 2021–2026
Table 56. Bluebird bio Recent Development
Table 57. Editas Medicine Company Details
Table 58. Editas Medicine Business Overview
Table 59. Editas Medicine Gene Therapy for Sickle Cell Disease Product
Table 60. Editas Medicine Revenue in Gene Therapy for Sickle Cell Disease Business (US$ Million), 2021–2026
Table 61. Editas Medicine Recent Development
Table 62. CRISPR Therapeutics Company Details
Table 63. CRISPR Therapeutics Business Overview
Table 64. CRISPR Therapeutics Gene Therapy for Sickle Cell Disease Product
Table 65. CRISPR Therapeutics Revenue in Gene Therapy for Sickle Cell Disease Business (US$ Million), 2021–2026
Table 66. CRISPR Therapeutics Recent Development
Table 67. Beam Therapeutics Company Details
Table 68. Beam Therapeutics Business Overview
Table 69. Beam Therapeutics Gene Therapy for Sickle Cell Disease Product
Table 70. Beam Therapeutics Revenue in Gene Therapy for Sickle Cell Disease Business (US$ Million), 2021–2026
Table 71. Beam Therapeutics Recent Development
Table 72. Intellia Therapeutics Company Details
Table 73. Intellia Therapeutics Business Overview
Table 74. Intellia Therapeutics Gene Therapy for Sickle Cell Disease Product
Table 75. Intellia Therapeutics Revenue in Gene Therapy for Sickle Cell Disease Business (US$ Million), 2021–2026
Table 76. Intellia Therapeutics Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report


List of Figures
Figure 1. Gene Therapy for Sickle Cell Disease Picture
Figure 2. Global Gene Therapy for Sickle Cell Disease Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Gene Therapy for Sickle Cell Disease Market Share by Type: 2025 vs 2032
Figure 4. Gene Addition Therapies Features
Figure 5. Gene Editing Therapies Features
Figure 6. Others Features
Figure 7. Global Gene Therapy for Sickle Cell Disease Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Gene Therapy for Sickle Cell Disease Market Share by Application: 2025 vs 2032
Figure 9. Children and Adolescents Case Studies
Figure 10. Adults Case Studies
Figure 11. Gene Therapy for Sickle Cell Disease Report Years Considered
Figure 12. Global Gene Therapy for Sickle Cell Disease Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Gene Therapy for Sickle Cell Disease Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Gene Therapy for Sickle Cell Disease Market Share by Region: 2025 vs 2032
Figure 15. Global Gene Therapy for Sickle Cell Disease Market Share by Players in 2025
Figure 16. Global Gene Therapy for Sickle Cell Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy for Sickle Cell Disease Revenue in 2025
Figure 18. North America Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Gene Therapy for Sickle Cell Disease Market Share by Country (2021–2032)
Figure 20. United States Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Gene Therapy for Sickle Cell Disease Market Share by Country (2021–2032)
Figure 24. Germany Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Gene Therapy for Sickle Cell Disease Market Share by Region (2021–2032)
Figure 32. China Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Gene Therapy for Sickle Cell Disease Market Share by Country (2021–2032)
Figure 40. Mexico Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Gene Therapy for Sickle Cell Disease Market Share by Country (2021–2032)
Figure 44. Israel Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Gene Therapy for Sickle Cell Disease Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Vertex Pharmaceuticals Revenue Growth Rate in Gene Therapy for Sickle Cell Disease Business (2021–2026)
Figure 48. Bluebird bio Revenue Growth Rate in Gene Therapy for Sickle Cell Disease Business (2021–2026)
Figure 49. Editas Medicine Revenue Growth Rate in Gene Therapy for Sickle Cell Disease Business (2021–2026)
Figure 50. CRISPR Therapeutics Revenue Growth Rate in Gene Therapy for Sickle Cell Disease Business (2021–2026)
Figure 51. Beam Therapeutics Revenue Growth Rate in Gene Therapy for Sickle Cell Disease Business (2021–2026)
Figure 52. Intellia Therapeutics Revenue Growth Rate in Gene Therapy for Sickle Cell Disease Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit